PATENT—D.R.I.: SUMMARY JUDGMENT DENIED IN LOESTRIN 24 ‘PAY-FOR-DELAY’ LITIGATION
(C.C.H.)
•
By Peter Reap, J.D., LL.M.
•
Copyright (c) CCH INCORPORATED, A Wolters Kluwer business. All rights reserved.
•
IP Law Daily
•
2020
•
News: Story
Wolters Kluwer Intellectual Property Law Daily
•
January 07, 2020
Branded Loestrin 24 oral contraceptive maker Warner Chilcott must go to trial over whether it violated antitrust laws by entering into settlements with generic manufacturers.
Warner Chilcott, the manufacturer of brand name oral contraceptive Loestrin...
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.